Integrating personalized genomic medicine into routine clinical care: addressing the social and policy issues of pharmacogenomic testing.

Abstract

The provision of personalized genomic medicine presents significant policy challenges, such as ensuring equitable patient access to testing, preparing clinicians to manage genomic results, justifying test reimbursement, sharing genomic information for patient care, and protecting patients against misuse of genetic information.